Home BioAtla

BioAtla

In operation
Seasoned Equity Offering
Novel Monoclonal Antibody and Cell Therapy Technology R&D Provider
Basic
Enterprise Profile

Basic Information

BioAtla is a San Diego-based biotechnology company that leverages its proprietary Conditionally Active Biologics™ (CAB) and Comprehensive Integrated Antibody Optimization (Ciao!™) platforms to develop novel monoclonal antibody and cell-based therapeutic technologies. BioAtla develops new treatment methods, improves therapeutic indicators, and has the potential to revolutionize cancer treatment.
BioAtla, LLC
SanDiego,California,United States of America
51~100 people
January 01, 2007
info@Bioatla.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products Immune Cell Therapy
Technology
Immunological Techniques Cell Technology
Concept
Therapeutic Products Ovarian Cancer
Application Scenarios
Innovative Drugs Monoclonal Antibody ADC (Antibody-Drug Conjugate) Cell and Gene Therapy